Yixin Wang

2.3k total citations · 4 hit papers
40 papers, 1.8k citations indexed

About

Yixin Wang is a scholar working on Immunology, Oncology and Biomedical Engineering. According to data from OpenAlex, Yixin Wang has authored 40 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 16 papers in Oncology and 16 papers in Biomedical Engineering. Recurrent topics in Yixin Wang's work include Nanoplatforms for cancer theranostics (10 papers), Immunotherapy and Immune Responses (8 papers) and RNA Interference and Gene Delivery (7 papers). Yixin Wang is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Immunotherapy and Immune Responses (8 papers) and RNA Interference and Gene Delivery (7 papers). Yixin Wang collaborates with scholars based in United States, China and Sweden. Yixin Wang's co-authors include Quanyin Hu, Zhaoting Li, Yingyue Ding, Jun Liu, Minjie Sun, Yu Chen, David Oupický, Fanyi Mo, Seungpyo Hong and Yuexin Shen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Chemical Society Reviews.

In The Last Decade

Yixin Wang

40 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemically and Biologically Engineered Bacteria‐Based Delivery Systems for Emerging Diagnosis and Advanced Therapy

2021 191 citations Zhaoting Li, Yixin Wang et al. Advanced Materials profile →
Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases

2022 176 citations Jun Liu, Yixin Wang et al. Science Advances profile →
Recent advances in overcoming barriers to cell‐based delivery systems for cancer immunotherapy

2022 170 citations Yingyue Ding, Yixin Wang et al. profile →
Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment

2022 148 citations Zhaoting Li, Yingyue Ding et al. Nature Communications profile →

Peers

Yixin Wang

IMMUN

ONCOL

BIOMA

Zhaoting Li China

Hao Qin China

Kyle C. Roche United States

Chao Wan China

Xiuwen Guan China

Ying‐Li Luo China

Min Luo China

Guangna Liu China

Shisong Han China

Lisen Lu China

Zhaoting Li China

Yixin Wang

699 ×0.9

675 ×0.9

577 ×1.2

IMMUN

371 ×1.1

ONCOL

246 ×0.9

BIOMA

Citations per year, relative to Yixin Wang Yixin Wang (= 1×) peers Zhaoting Li

Countries citing papers authored by Yixin Wang

Since Specialization

Citations

This map shows the geographic impact of Yixin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yixin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yixin Wang more than expected).

Fields of papers citing papers by Yixin Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yixin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yixin Wang. The network helps show where Yixin Wang may publish in the future.

Co-authorship network of co-authors of Yixin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yixin Wang. A scholar is included among the top collaborators of Yixin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yixin Wang. Yixin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Zhaoting, et al.. (2025). Engineering pyroptotic vesicles as personalized cancer vaccines. Nature Nanotechnology. 20(8). 1108–1118. 7 indexed citations

Wang, Yixin, et al.. (2024). Nanotechnology‐Assisted CAR‐T‐Cell Therapy for Tumor Treatment. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 16(5). e2005–e2005. 5 indexed citations

Li, Zhaoting, Fanyi Mo, Kai Guo, et al.. (2024). Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against pancreatic cancer. Med. 5(4). 348–367.e7. 14 indexed citations

Li, Zhaoting, Yueyang Deng, Honghao Sun, et al.. (2023). Redox modulation with a perfluorocarbon nanoparticle to reverse Treg-mediated immunosuppression and enhance anti-tumor immunity. Journal of Controlled Release. 358. 579–590. 17 indexed citations

Wang, Yixin, et al.. (2023). Targeting Macrophages for Tumor Therapy. The AAPS Journal. 25(5). 80–80. 7 indexed citations

Wang, Yixin, et al.. (2023). Nano-STING agonist-decorated microrobots boost innate and adaptive anti-tumor immunity. Nano Research. 16(7). 9848–9858. 13 indexed citations

Li, Zhaoting, Fanyi Mo, Yixin Wang, et al.. (2022). Enhancing Gasdermin-induced tumor pyroptosis through preventing ESCRT-dependent cell membrane repair augments antitumor immune response. Nature Communications. 13(1). 6321–6321. 94 indexed citations

Dong, Jingwen, Jing Li, Zheng Wang, et al.. (2022). Reversing the PAI-1-induced fibrotic immune exclusion of solid tumor by multivalent CXCR4 antagonistic nano-permeator. Acta Pharmaceutica Sinica B. 13(7). 3106–3120. 7 indexed citations

Li, Feng, Bin-Chi Liao, Ting Wang, Tingting Qi, & Yixin Wang. (2022). Programmed Cell Death Protein 1/Programmed Cell Death Protein Ligand 1 Immunosuppressants in Advanced Non-Small Cell Lung Cancer Research Progress in Treatment. Frontiers in Pharmacology. 13. 918709–918709. 5 indexed citations

10.

Li, Zhaoting, Yingyue Ding, Jun Liu, et al.. (2022). Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment. Nature Communications. 13(1). 1845–1845. 148 indexed citations breakdown →

11.

Wang, Yixin, et al.. (2021). Oscillating field stimulation promotes axon regeneration and locomotor recovery after spinal cord injury. Neural Regeneration Research. 17(6). 1318–1318. 3 indexed citations

12.

Li, Zhaoting, Yixin Wang, Jun Liu, et al.. (2021). Chemically and Biologically Engineered Bacteria‐Based Delivery Systems for Emerging Diagnosis and Advanced Therapy. Advanced Materials. 33(38). e2102580–e2102580. 191 indexed citations breakdown →

13.

Li, Zhaoting, Yixin Wang, Yuexin Shen, et al.. (2020). Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy. Science Advances. 6(20). eaaz9240–eaaz9240. 144 indexed citations

14.

Chen, Gang, et al.. (2020). The effects of fluoroalkyl chain length and density on siRNA delivery of bioreducible poly(amido amine)s. European Journal of Pharmaceutical Sciences. 152. 105433–105433. 9 indexed citations

15.

Li, Zhaoting, Yuexin Shen, Yixin Wang, et al.. (2019). Perfluorocarbon Nanoemulsions for Combined Pulmonary siRNA Treatment of Lung Metastatic Osteosarcoma. Advanced Therapeutics. 2(7). 14 indexed citations

16.

Li, Zhaoting, Gang Chen, Ling Ding, et al.. (2019). Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions. Molecular Therapy. 27(12). 2100–2110. 39 indexed citations

17.

Chen, Gang, Yixin Wang, Pengkai Wu, et al.. (2018). Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer. ACS Nano. 12(7). 6620–6636. 50 indexed citations

18.

Jin, Yi, Lars Muhl, Mikhail Burmakin, et al.. (2017). Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling. Nature Cell Biology. 19(6). 639–652. 141 indexed citations

19.

Chen, Gang, Kaikai Wang, Yixin Wang, et al.. (2017). Fluorination Enhances Serum Stability of Bioreducible Poly(amido amine) Polyplexes and Enables Efficient Intravenous siRNA Delivery. Advanced Healthcare Materials. 7(5). 37 indexed citations

20.

Connelly, Mark C., Yixin Wang, Gerald V. Doyle, Leon W.M.M. Terstappen, & Robert McCormack. (2009). Re: Anti–Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells. JNCI Journal of the National Cancer Institute. 101(12). 895–895. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact